These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 28195079)

  • 1. Update on etiopathogenesis and treatment of Acne.
    Bhat YJ; Latief I; Hassan I
    Indian J Dermatol Venereol Leprol; 2017; 83(3):298-306. PubMed ID: 28195079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From pathogenesis of acne vulgaris to anti-acne agents.
    Cong TX; Hao D; Wen X; Li XH; He G; Jiang X
    Arch Dermatol Res; 2019 Jul; 311(5):337-349. PubMed ID: 30859308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acne and sebaceous gland function.
    Zouboulis CC
    Clin Dermatol; 2004; 22(5):360-6. PubMed ID: 15556719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel anti-acne actions of nadifloxacin and clindamycin that inhibit the production of sebum, prostaglandin E(2) and promatrix metalloproteinase-2 in hamster sebocytes.
    Sato T; Shirane T; Noguchi N; Sasatsu M; Ito A
    J Dermatol; 2012 Sep; 39(9):774-80. PubMed ID: 22394009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acne: topical treatment.
    Krautheim A; Gollnick HP
    Clin Dermatol; 2004; 22(5):398-407. PubMed ID: 15556726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ozenoxacin suppresses sebum production by inhibiting mTORC1 activation in differentiated hamster sebocytes.
    Kitano T; Koiwai T; Fujikawa K; Mori S; Matsumoto T; Sato T
    J Dermatol; 2024 Sep; 51(9):1187-1198. PubMed ID: 39087744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nadifloxacin, an antiacne quinolone antimicrobial, inhibits the production of proinflammatory cytokines by human peripheral blood mononuclear cells and normal human keratinocytes.
    Kuwahara K; Kitazawa T; Kitagaki H; Tsukamoto T; Kikuchi M
    J Dermatol Sci; 2005 Apr; 38(1):47-55. PubMed ID: 15795123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel pharmacological approaches for the treatment of acne vulgaris.
    Valente Duarte de Sousa IC
    Expert Opin Investig Drugs; 2014 Oct; 23(10):1389-410. PubMed ID: 24890096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Augmentation of gene expression and production of promatrix metalloproteinase 2 by Propionibacterium acnes-derived factors in hamster sebocytes and dermal fibroblasts: a possible mechanism for acne scarring.
    Sato T; Kurihara H; Akimoto N; Noguchi N; Sasatsu M; Ito A
    Biol Pharm Bull; 2011; 34(2):295-9. PubMed ID: 21415544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strategic Targets in Acne: The Comedone Switch in Question.
    Saurat JH
    Dermatology; 2015; 231(2):105-11. PubMed ID: 26113292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TRPV3 promotes sebocyte inflammation via transcriptional modulating TLR2 in acne.
    Wei Z; Gao M; Liu Y; Zeng R; Liu J; Sun S; Li S; Hu L; Xiang R; Mo R; Song Z; Chen Z; Bao D; Hua D; Zouboulis CC; Feng Y; Li J; Yang Y
    Biochim Biophys Acta Mol Basis Dis; 2024 Jun; 1870(5):167195. PubMed ID: 38648901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acne vulgaris: The metabolic syndrome of the pilosebaceous follicle.
    Melnik BC
    Clin Dermatol; 2018; 36(1):29-40. PubMed ID: 29241749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salicylic acid treats acne vulgaris by suppressing AMPK/SREBP1 pathway in sebocytes.
    Lu J; Cong T; Wen X; Li X; Du D; He G; Jiang X
    Exp Dermatol; 2019 Jul; 28(7):786-794. PubMed ID: 30972839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of dihydrotestosterone on the upregulation of inflammatory cytokines in cultured sebocytes.
    Lee WJ; Jung HD; Chi SG; Kim BS; Lee SJ; Kim DW; Kim MK; Kim JC
    Arch Dermatol Res; 2010 Aug; 302(6):429-33. PubMed ID: 20043171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical acne treatments in Europe and the issue of antimicrobial resistance.
    Leccia MT; Auffret N; Poli F; Claudel JP; Corvec S; Dreno B
    J Eur Acad Dermatol Venereol; 2015 Aug; 29(8):1485-92. PubMed ID: 25677763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cortexolone 17α-propionate (Clascoterone) Is a Novel Androgen Receptor Antagonist that Inhibits Production of Lipids and Inflammatory Cytokines from Sebocytes In Vitro.
    Rosette C; Agan FJ; Mazzetti A; Moro L; Gerloni M
    J Drugs Dermatol; 2019 May; 18(5):412-418. PubMed ID: 31141847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 11β-hydroxysteroid dehydrogenase type 1 is expressed in human sebaceous glands and regulates glucocorticoid-induced lipid synthesis and toll-like receptor 2 expression in SZ95 sebocytes.
    Lee SE; Kim JM; Jeong MK; Zouboulis CC; Lee SH
    Br J Dermatol; 2013 Jan; 168(1):47-55. PubMed ID: 22897663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What is new in the pathophysiology of acne, an overview.
    Dréno B
    J Eur Acad Dermatol Venereol; 2017 Sep; 31 Suppl 5():8-12. PubMed ID: 28805938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolving perspectives on the etiology and pathogenesis of acne vulgaris.
    Eichenfield LF; Del Rosso JQ; Mancini AJ; Cook-Bolden F; Stein Gold L; Desai S; Weiss J; Pariser D; Zeichner J; Bhatia N; Kircik L
    J Drugs Dermatol; 2015 Mar; 14(3):263-72. PubMed ID: 25738848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxisome proliferator-activated receptor activators protect sebocytes from apoptosis: a new treatment modality for acne?
    Schuster M; Zouboulis CC; Ochsendorf F; Müller J; Thaçi D; Bernd A; Kaufmann R; Kippenberger S
    Br J Dermatol; 2011 Jan; 164(1):182-6. PubMed ID: 21091942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.